• Japanese
  • Korean
  • Chinese
Cover Image

Autoinjectors to 2020: Devices, Markets, Players, Strategies and Forecasts

Greystone Research Associates is pleased to announce the publication of a new market study. Autoinjectors to 2018: Devices, Therapeutics, Markets, Strategies and Prospects is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for autoinjectors designed to accept a prefilled syringe and simplify the injection process for self-administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Converging Factors Driving the Growth of Autoinjectors

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. For drugs developed for self-administration, autoinjectors have been shown to provide a more user-friendly outer package and improved compliance. While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Until recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to the creation of a class of autoinjectors that can be made economically in high production quantities, opening the door for the disposable autoinjector, and providing expanded opportunities for both patient and drug marketer.

Feature Summary

  • Provides detailed analysis of autoinjectors for injectable drug delivery, and assesses key market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial devices in five key product segments
  • Analyzes design factors, material selection issues, technologies and market development issues
  • Charts market data and forecasts to 2018
  • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access
  • Evaluates the impact of economic, technology, and regulatory factors

Methodology

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.

Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.

Table of Contents

Executive Summary

The Market Opportunity

  • Delivery Market Dynamics
  • The Economics of Injectable Drugs
  • What's Driving the Growth in Autoinjectors?
    • Prefilled Syringes Proliferating
    • The Trend toward Self-Administration
    • Shifting Demographics
    • Innovation in Disposable Device Designs
    • Therapeutic Demand Drivers
  • Competitive Landscape
  • Risk Factors

Autoinjectors - Commercial Devices

  • Manual injection Autoinjectors
  • Automated Injection Autoinjectors
  • Reusable Autoinjectors
  • Disposable Autoinjectors
  • Variable Dose Autoinjectors
  • Product Specific Autoinjectors

Autoinjector Device Design Factors

  • Material Selection Issues
  • Part Counts and Device Cost
  • Safety Features
  • Needle Shielding
  • Needle Insertion Depth
  • Failsafe Activation
  • Dose Inspection/Injection Confirmation
  • Lyophilized Drugs/Reconstitution
  • Human Engineering/Ergonomics

Autoinjector Drug Delivery - Key Therapeutic Sector Analysis

  • Anticoagulants
  • Autoimmune Diseases
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Psoriasis
  • Emergency Medicine
  • Hepatitis
  • Hematopoietics
  • Hormones
  • Reproductive Health

Market Factors

  • Regulatory Issues
  • Device Branding
  • Patient Compliance and Ease of Use
  • Healthcare Economics

Company Profiles

Show More
Pricing
Get Notified
Email me when related reports are published